831
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Metformin enhances epithelial cell growth inhibition via the protein kinase–insulin-like growth factor binding protein-1 pathway

, , &
Article: 2321651 | Received 19 Mar 2023, Accepted 14 Jan 2024, Published online: 11 Mar 2024

References

  • Arnold, J.T., et al., 2001. Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model. Human Reproduction (Oxford, England), 16 (5), 1–7.
  • Asati, V., et al., 2016. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives. European Journal of Medicinal Chemistry, 109, 314–341.
  • Chen, Q., et al., 2018. USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1/MEK/ERK pathway. American Journal of Physiology. Cell Physiology, 315 (6), C863–c872.
  • Cunha-Filho, J.S., et al., 2003. Insulin-like growth factor (IGF)-1 and IGF binding protein-1 and -3 in the follicular fluid of infertile patients with endometriosis. Human Reproduction (Oxford, England), 18 (2), 423–428.
  • Figueroa, J.A., et al., 1993. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. Journal of Cellular Physiology, 157 (2), 229–236.
  • Graham, G.G., et al., 2011. Clinical pharmacokinetics of metformin. Clinical Pharmacokinetics, 50 (2), 81–98.
  • Guzel, E., et al., 2011. Bidirectional interaction between unfolded-protein-response key protein HSPA5 and estrogen signaling in human endometrium. Biology of Reproduction, 85 (1), 121–127.
  • Horne, A.W. and Missmer, S.A., 2022. Pathophysiology, diagnosis, and management of endometriosis. BMJ (Clinical Research ed.), 379, e070750.
  • Irwin, J.C., et al., 1999. Role of the IGF system in trophoblast invasion and pre-eclampsia. Human Reproduction (Oxford, England), 14 Suppl 2, 90–96.
  • Isoda, K., et al., 2006. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 26 (3), 611–617.
  • Lin, X., et al., 2023. KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/MAPK pathway in an m(6)A-dependent manner. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 66, 100908.
  • Lin, Y.W., et al., 2021. IGFBP-1 in cancer: expression, molecular mechanisms, and potential clinical implications. American Journal of Translational Research, 13 (3), 813–832.
  • Meola, J., et al., 2010. Differentially expressed genes in eutopic and ectopic endometrium of women with endometriosis. Fertility and Sterility, 93 (6), 1750–1773.
  • Murphy, L.J. and Ghahary, A., 1990. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocrine Reviews, 11 (3), 443–453.
  • Pawelczyk, L., et al., 2004. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 113 (2), 209–213.
  • Seppälä, M., et al., 1994. Uterine endocrinology and paracrinology: insulin-like growth factor binding protein-1 and placental protein 14 revisited. Human Reproduction (Oxford, England), 9 (5), 917–925.
  • Shih, A.J., et al., 2022. Single-cell analysis of menstrual endometrial tissues defines phenotypes associated with endometriosis. BMC Medicine, 20 (1), 315.
  • Tang, Q., et al., 2017a. Emodin increases expression of insulin-like growth factor binding protein 1 through activation of MEK/ERK/AMPKalpha and interaction of PPARgamma and Sp1 in lung cancer. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 41 (1), 339–357.
  • Tang, Q., et al., 2017b. Combination of solamargine and metformin strengthens IGFBP1 gene expression through inactivation of Stat3 and reciprocal interaction between FOXO3a and SP1. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 43 (6), 2310–2326.
  • Taylor, H.S., et al., 2021. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet (London, England), 397 (10276), 839–852.
  • Wang, J., et al., 2019. The prognostic values of insulin-like growth factor binding protein in breast cancer. Medicine, 98 (19), e15561.
  • Wang, Q. and Wei, X., 2024. Research progress on the use of metformin in leukemia treatment. Current Treatment Options in Oncology, 25 (2), 220–236.
  • Xu, X., et al., 2024. Regulation of AMPK activation by extracellular matrix stiffness in pancreatic cancer. Genes & Diseases, 11 (3), 101035.
  • Xue, J., et al., 2013. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction, 146 (4), 397–406.
  • Yang, L.J., et al., 2016. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research, 35 (1), 59.
  • Yoo, J.Y., et al., 2018. MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT. BMC Cancer, 18 (1), 605.
  • Zhang, H., et al., 2010. Endometriotic epithelial cells induce MMPs expression in endometrial stromal cells via an NFkappaB-dependent pathway. Gynecological Endocrinology, 26 (6), 456–467.
  • Zhang, H., et al., 2015. Metformin regulates stromal-epithelial cells communication via Wnt2/beta-catenin signaling in endometriosis. Molecular and Cellular Endocrinology, 413, 61–65.
  • Zhou, X., et al., 2023. Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells. Cancer Letters, 577, 216422.